LncRNA MDRL Mitigates Atherosclerosis through miR-361/SQSTM1/NLRP3 Signaling

Objective. Long non-coding RNAs (lncRNAs) play many important roles in gene regulation and disease pathogenesis. Here, we sought to determine that mitochondrial dynamic related lncRNA (MDRL) modulates NLRP3 inflammasome activation and apoptosis of vascular smooth muscle cells (VSMCs) and protects ar...

Full description

Saved in:
Bibliographic Details
Main Authors: Ling You, Yanjie Zheng, Jing Yang, Qian Hou, Lianxia Wang, Yan Zhang, Chunxia Zhao, Ruiqin Xie
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2022/5463505
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832563509372649472
author Ling You
Yanjie Zheng
Jing Yang
Qian Hou
Lianxia Wang
Yan Zhang
Chunxia Zhao
Ruiqin Xie
author_facet Ling You
Yanjie Zheng
Jing Yang
Qian Hou
Lianxia Wang
Yan Zhang
Chunxia Zhao
Ruiqin Xie
author_sort Ling You
collection DOAJ
description Objective. Long non-coding RNAs (lncRNAs) play many important roles in gene regulation and disease pathogenesis. Here, we sought to determine that mitochondrial dynamic related lncRNA (MDRL) modulates NLRP3 inflammasome activation and apoptosis of vascular smooth muscle cells (VSMCs) and protects arteries against atherosclerosis. Methods. In vivo experiments, we applied LDLR knockout (LDLR-/-) mice fed the high-fat diet to investigate the effects of MDRL on atherosclerosis. In vitro experiments, we applied mouse aortic smooth muscle cells to determine the mechanism of MDRL in abrogating NLRP3 inflammasome and inhibiting cell apoptosis through miR-361/sequentosome 1 (SQSTM1) by TUNEL staining, quantitative RT-PCR, western blot, microribonucleoprotein immunoprecipitation, and luciferase reporter assay. Results. Downregulated MDRL and increased NLRP3 were observed in mouse atherosclerotic plaques, accompanied with the increase of miR-361. The results showed that MDRL overexpression significantly attenuated the burden of atherosclerotic plaque and facilitated plaque stability through inhibiting NLRP3 inflammasome activation and cell apoptosis, and vice versa. Mechanically, MDRL suppressed NLRP3 inflammasome activation and VSMC apoptosis via suppressing miR-361. Furthermore, miR-361 directly bound to the 3’UTR of SQSTM1 and inhibited its translation, subsequently activating NLRP3 inflammasome. Systematic delivery of miR-361 partly counteracted the beneficial effects of MDRL overexpression on atherosclerotic development in LDLR-/- mice. Conclusions. In summary, MDRL alleviates NLRP3 inflammasome activation and apoptosis in VSMCs through miR-361/SQSTM1/NLRP3 pathway during atherogenesis. These data indicate that MDRL and inhibition of miR-361 represent potential therapeutic targets in atherosclerosis-related diseases.
format Article
id doaj-art-9776572932854c838247321fb7a38d6e
institution Kabale University
issn 1466-1861
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-9776572932854c838247321fb7a38d6e2025-02-03T01:20:06ZengWileyMediators of Inflammation1466-18612022-01-01202210.1155/2022/5463505LncRNA MDRL Mitigates Atherosclerosis through miR-361/SQSTM1/NLRP3 SignalingLing You0Yanjie Zheng1Jing Yang2Qian Hou3Lianxia Wang4Yan Zhang5Chunxia Zhao6Ruiqin Xie7Division of CardiologyDivision of CardiologyDivision of CardiologyDivision of CardiologyDivision of CardiologyDivision of CardiologyInstitute of Hypertension and Department of Internal MedicineDivision of CardiologyObjective. Long non-coding RNAs (lncRNAs) play many important roles in gene regulation and disease pathogenesis. Here, we sought to determine that mitochondrial dynamic related lncRNA (MDRL) modulates NLRP3 inflammasome activation and apoptosis of vascular smooth muscle cells (VSMCs) and protects arteries against atherosclerosis. Methods. In vivo experiments, we applied LDLR knockout (LDLR-/-) mice fed the high-fat diet to investigate the effects of MDRL on atherosclerosis. In vitro experiments, we applied mouse aortic smooth muscle cells to determine the mechanism of MDRL in abrogating NLRP3 inflammasome and inhibiting cell apoptosis through miR-361/sequentosome 1 (SQSTM1) by TUNEL staining, quantitative RT-PCR, western blot, microribonucleoprotein immunoprecipitation, and luciferase reporter assay. Results. Downregulated MDRL and increased NLRP3 were observed in mouse atherosclerotic plaques, accompanied with the increase of miR-361. The results showed that MDRL overexpression significantly attenuated the burden of atherosclerotic plaque and facilitated plaque stability through inhibiting NLRP3 inflammasome activation and cell apoptosis, and vice versa. Mechanically, MDRL suppressed NLRP3 inflammasome activation and VSMC apoptosis via suppressing miR-361. Furthermore, miR-361 directly bound to the 3’UTR of SQSTM1 and inhibited its translation, subsequently activating NLRP3 inflammasome. Systematic delivery of miR-361 partly counteracted the beneficial effects of MDRL overexpression on atherosclerotic development in LDLR-/- mice. Conclusions. In summary, MDRL alleviates NLRP3 inflammasome activation and apoptosis in VSMCs through miR-361/SQSTM1/NLRP3 pathway during atherogenesis. These data indicate that MDRL and inhibition of miR-361 represent potential therapeutic targets in atherosclerosis-related diseases.http://dx.doi.org/10.1155/2022/5463505
spellingShingle Ling You
Yanjie Zheng
Jing Yang
Qian Hou
Lianxia Wang
Yan Zhang
Chunxia Zhao
Ruiqin Xie
LncRNA MDRL Mitigates Atherosclerosis through miR-361/SQSTM1/NLRP3 Signaling
Mediators of Inflammation
title LncRNA MDRL Mitigates Atherosclerosis through miR-361/SQSTM1/NLRP3 Signaling
title_full LncRNA MDRL Mitigates Atherosclerosis through miR-361/SQSTM1/NLRP3 Signaling
title_fullStr LncRNA MDRL Mitigates Atherosclerosis through miR-361/SQSTM1/NLRP3 Signaling
title_full_unstemmed LncRNA MDRL Mitigates Atherosclerosis through miR-361/SQSTM1/NLRP3 Signaling
title_short LncRNA MDRL Mitigates Atherosclerosis through miR-361/SQSTM1/NLRP3 Signaling
title_sort lncrna mdrl mitigates atherosclerosis through mir 361 sqstm1 nlrp3 signaling
url http://dx.doi.org/10.1155/2022/5463505
work_keys_str_mv AT lingyou lncrnamdrlmitigatesatherosclerosisthroughmir361sqstm1nlrp3signaling
AT yanjiezheng lncrnamdrlmitigatesatherosclerosisthroughmir361sqstm1nlrp3signaling
AT jingyang lncrnamdrlmitigatesatherosclerosisthroughmir361sqstm1nlrp3signaling
AT qianhou lncrnamdrlmitigatesatherosclerosisthroughmir361sqstm1nlrp3signaling
AT lianxiawang lncrnamdrlmitigatesatherosclerosisthroughmir361sqstm1nlrp3signaling
AT yanzhang lncrnamdrlmitigatesatherosclerosisthroughmir361sqstm1nlrp3signaling
AT chunxiazhao lncrnamdrlmitigatesatherosclerosisthroughmir361sqstm1nlrp3signaling
AT ruiqinxie lncrnamdrlmitigatesatherosclerosisthroughmir361sqstm1nlrp3signaling